Download Medical Notes on Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech

Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech Medical Notes

About This Presentation

Description:Biopharma and Medtech are certainly leading the fight against coronavirus COVID-19. However, they are certainly not immune from the adverse economic impact of the pandemic. We are witnessing a devastating effect of the coronavirus COVID-19 pandemic on global health and economies. And as expected, the biopharma and medtech sectors are under tremendous pressure to come up with solutions to relieve the humanity at record speed. This Evaluate Vantage COVID-19 Report throws light on the progress so far, to deduce which treatments and vaccines are expected to deliver in the fight against the virus. The report also discusses the wider effect the global pandemic is having on the biopharma and medtech sector. This includes share price declines, the potential financial implications, the cost of delays, deals being triggered by the pandemic, Biopharma and medtech’s response, the impact on biophar

Tags:EvaluatePharma, pharmaceutical industry, pharma, pharmaceutical, financial markets, R&D, Biopharma, Medtech, coronavirus, COVID-19, pandemic, vaccines

Published on: Jun 29, 2020 | Views : 1273 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

Specialty Pharmacy and Biosimilars

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

Pharmacoeconomics

2019 R&D Achievements New product launches, clinical trial activity, and investments

COVID-19 immunology research

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 1

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

The Pharmaceutical Industry in Europe – Facts and Figure

HEALTH A TO Z